Literature DB >> 24462575

The serine protease inhibitor Ecotin is required for full virulence of Burkholderia pseudomallei.

Philip M Ireland1, Laura Marshall2, Isobel Norville2, Mitali Sarkar-Tyson3.   

Abstract

Burkholderia pseudomallei is a Gram negative soil saprophyte that causes the disease melioidosis where clinical symptoms can vary from localised infection to pneumonia and septic shock. Ecotin is a potent periplasmic serine protease inhibitor first identified in Escherichia coli. Ecotin, although present in only a small subset of genera, can inhibit a broad range of serine proteases including those typically associated with the innate immune system such as neutrophil elastase and cathepsin G. An Ecotin orthologue identified in B. pseudomallei was recombinantly expressed and found to inhibit elastase. To study the role of Ecotin in B. pseudomallei virulence an in-frame unmarked deletion mutant was created. Infection of a murine macrophages-like cell line revealed Ecotin was necessary for the early stages of colonisation allowing replication following cell entry. Attenuation of the Δeco mutant strain in the murine model of melioidosis further supported Ecotin as a virulence factor of B. pseudomallei.
Copyright © 2014. Published by Elsevier Ltd.

Entities:  

Keywords:  Burkholderia pseudomallei; Ecotin; Macrophage; Serine protease; Virulence

Mesh:

Substances:

Year:  2014        PMID: 24462575     DOI: 10.1016/j.micpath.2014.01.001

Source DB:  PubMed          Journal:  Microb Pathog        ISSN: 0882-4010            Impact factor:   3.738


  9 in total

Review 1.  Human Melioidosis.

Authors:  I Gassiep; M Armstrong; R Norton
Journal:  Clin Microbiol Rev       Date:  2020-03-11       Impact factor: 26.132

Review 2.  Melioidosis: molecular aspects of pathogenesis.

Authors:  Joshua K Stone; David DeShazer; Paul J Brett; Mary N Burtnick
Journal:  Expert Rev Anti Infect Ther       Date:  2014-10-14       Impact factor: 5.091

3.  Proteomic analysis of the Burkholderia pseudomallei type II secretome reveals hydrolytic enzymes, novel proteins, and the deubiquitinase TssM.

Authors:  Mary N Burtnick; Paul J Brett; David DeShazer
Journal:  Infect Immun       Date:  2014-05-27       Impact factor: 3.441

4.  A general protein O-glycosylation machinery conserved in Burkholderia species improves bacterial fitness and elicits glycan immunogenicity in humans.

Authors:  Yasmine Fathy Mohamed; Nichollas E Scott; Antonio Molinaro; Carole Creuzenet; Ximena Ortega; Ganjana Lertmemongkolchai; Michael M Tunney; Heather Green; Andrew M Jones; David DeShazer; Bart J Currie; Leonard J Foster; Rebecca Ingram; Cristina De Castro; Miguel A Valvano
Journal:  J Biol Chem       Date:  2019-07-26       Impact factor: 5.157

Review 5.  Melioidosis.

Authors:  W Joost Wiersinga; Harjeet S Virk; Alfredo G Torres; Bart J Currie; Sharon J Peacock; David A B Dance; Direk Limmathurotsakul
Journal:  Nat Rev Dis Primers       Date:  2018-02-01       Impact factor: 52.329

6.  Host-targeted niclosamide inhibits C. difficile virulence and prevents disease in mice without disrupting the gut microbiota.

Authors:  John Tam; Therwa Hamza; Bing Ma; Kevin Chen; Greg L Beilhartz; Jacques Ravel; Hanping Feng; Roman A Melnyk
Journal:  Nat Commun       Date:  2018-12-07       Impact factor: 14.919

7.  Characterization of ecotin homologs from Campylobacter rectus and Campylobacter showae.

Authors:  Cody Thomas; Harald Nothaft; Ruchi Yadav; Christopher Fodor; Abofu Alemka; Oluwadamilola Oni; Michael Bell; Balázs Rada; Christine M Szymanski
Journal:  PLoS One       Date:  2020-12-30       Impact factor: 3.240

8.  Synergy of protease-binding sites within the ecotin homodimer is crucial for inhibition of MASP enzymes and for blocking lectin pathway activation.

Authors:  Zoltán Attila Nagy; Dávid Héja; Dániel Bencze; Bence Kiss; Eszter Boros; Dávid Szakács; Krisztián Fodor; Matthias Wilmanns; Andrea Kocsis; József Dobó; Péter Gál; Veronika Harmat; Gábor Pál
Journal:  J Biol Chem       Date:  2022-04-25       Impact factor: 5.486

9.  Ecotin, a microbial inhibitor of serine proteases, blocks multiple complement dependent and independent microbicidal activities of human serum.

Authors:  Zoltán Attila Nagy; Dávid Szakács; Eszter Boros; Dávid Héja; Eszter Vígh; Noémi Sándor; Mihály Józsi; Gábor Oroszlán; József Dobó; Péter Gál; Gábor Pál
Journal:  PLoS Pathog       Date:  2019-12-20       Impact factor: 6.823

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.